C71T
CANCELLED SECTION 71
02/06/2026
Back to search
Official data from USPTO
GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/03/2026
Trademark type
Combined
Nice classes
5, 36, 41, 42
Filing date
04/17/2018
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
CALLAGHAN, BRIAN P
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP" appearing to the right of a design consisting of four circular elements and an abstract design incorporated within said circular elements.
Holders and representatives
Holders
G. F. (pessoa física)
D. I. (pessoa física)
Representatives
Glenn A. Gundersen Dechert LLP
Technical classification
Nice Classes
Class 5Class 36Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsvaccines and antimicrobial preparations for treating bacterial infectionsviral infections and fungi; veterinary productsvaccinesantibiotics and antimicrobial preparations for treating bacterial infectionsviral infections and fungi in animals; disinfectants
Class 36
Financial affairsnamely financial informationmanagement and analysis services; charitable fundraising and financial investment management in the field of medical and scientific research and development; funding of research and development programs in the medical field
Class 41
Educational servicesnamely conducting classesseminarsconferences and workshops in the fields of medical and scientific research and development and public health; training in the fields of medical and scientific research and development and public health; organizing and conducting of congressesconferencescolloquiums and seminars on medical research and developmentuse and conservation of new antibiotics; publication of books and journals in the medical and public health field; publication of online journals in the medical and public health field
Class 42
Industrial analysis and research services in the field of antimicrobials; design and development of software; scientific research for medical purposes in the field of antimicrobials; scientific analysis and research in the field of bacteriology; scientific research for the development of antibiotics; pharmaceutical drug development and diagnostics in the field of antibiotics
Publications
History of USPTO decisions and trademark events.
31 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/23/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/14/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
11/14/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/03/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/15/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/15/2019
RFNT
REFUSAL PROCESSED BY IB
09/08/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/23/2018
RFRR
REFUSAL PROCESSED BY MPU
08/23/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/14/2018
CNRT
NON-FINAL ACTION WRITTEN
08/13/2018
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2018
DOCK
ASSIGNED TO EXAMINER
08/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/02/2018
Continuous trademark protection
Get notified about every new filing that threatens GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.